Jersey City, New Jersey, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Transdermal Drug Delivery Systems Market” By Type (Transdermal Patches and Transdermal Semisolids), By Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, and Others), By Geographic Scope And Forecast.
As per the deep research carried out by Verified Market Research, the global Transdermal Drug Delivery Systems Market size was valued at USD 5.9 Billion in 2020 and is projected to reach USD 8.4 Billion by 2028, growing at a CAGR of 4.5% from 2021 to 2028.
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=27974
Browse in-depth TOC on “Transdermal Drug Delivery Systems Market”
202 - Pages
126 – Tables
37 – Figures
Global Transdermal Drug Delivery Systems Market Overview
Transdermal drug delivery systems are used to deliver the drug through the skin’s dermal layer for maintaining required systemic circulation over a predetermined period. It uses a medicated adhesive bandage that is applied to the skin which then releases the drug into the bloodstream through the skin. As the drug is administered through the skin, it reduces the strain put by the drug on the digestive tract and liver. Transdermal drug delivery systems improve the efficacy of drugs while maintaining their safety. These delivery systems also help maintain a steady drug concentration in blood plasma.
A significant scientific advantage for ongoing success is the ability of the transdermal drug delivery system to provide sustained blood levels with minimal peak-to-trough variation via a non-oral, noninjectable route of delivery. In addition, technological advancements in transdermal drug delivery systems are also expected to support market growth in the coming years. The advanced technology is transdermal patch design modification, pressure-sensitive adhesives, and permeation enhancers that enhance drug diffusion and increase the capacity to hold the drug in excess. A passive-delivery patch is also the only dosage form that can bridge the dosing interval gap between once-a-day dosing, addressed by oral dosage forms, and a once-a-week or more extended dosing, handled by depot injection products.
When matched with the right drugs, these unique features and other advantageous attributes of the transdermal drug delivery system provide compelling and differentiating medical benefits to all stakeholders. Moreover, the growing geriatric population and the rise of several chronic diseases such as orthopedic diseases and other disorders among older adults fuel the demand for transdermal drug delivery patches. In addition, the transdermal drug delivery system offers several benefits, such as enhanced safety, efficacy, and reduced inter-patient variability of doses. These are some of the factors favoring the Transdermal Drug Delivery Systems Market growth. Additionally, the transdermal drug delivery system reduces the risk and inconveniences of parenteral therapy and the increased demand for minimally invasive treatments, which is expected to boost the global Transdermal Drug Delivery Systems Market. Besides, growing spending on healthcare by the people is anticipated to impact the market’s growth positively.
Key Players
The major players in the market are Novartis AG, Johnson & Johnson Services, ALLERGAN, GlaxoSmithKline, IBSA Institut Biochimque SA, Pfizer, 3M Pharmaceuticals, Bayer Crop Science, Johnson & Johnson Limited, and Noven Pharmaceuticals.
Verified Market Research has segmented the Global Transdermal Drug Delivery Systems Market On the basis of Type, Application, and Geography.
- Transdermal Drug Delivery Systems Market, By Type
- Transdermal Patches
- Transdermal Semisolids
- Transdermal Drug Delivery Systems Market, By Application
- Cardiovascular Diseases
- Central Nervous System Disorders
- Hormonal Applications
- Pain Management
- Others
- Transdermal Drug Delivery Systems Market, By Geography
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- U.K
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- ROW
- Middle East & Africa
- Latin America
- North America
Browse Related Reports:
Drug-Eluting Stents Market By Product (Polymer-Based, Polymer-Free), By Application (Coronary Diseases, Peripheral Vascular Diseases), By End-User (Hospitals, Ambulatory Surgical Centers, Cardiology Centers), By Geography, And Forecast
Diabetes Devices Market By Product (Blood Glucose Monitoring, Insulin Delivery, Pens and Pen Needles), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics and Centers), By End-Use Outlook (Hospitals, Homecare, Diagnostic Centers), By Geography, And Forecast
Human Insulin Market By Application (Type I Diabetes, Type II Diabetes), By Delivery Device (Syringes, Pens, Pen Needles), By Brand (HI Analogs And Biosimilars, HI Biologics), By Type (Insulin Analogs And Biosimilars, HI Biologics), By Product Type (HI Drugs, HI Delivery Devices), By Geography, And Forecast
Antibody Drug Conjugates Market By Product (Adcetris, Kadcyla), By Application (Breast Cancer, Lymphoma), By Geography, And Forecast
Top 5 Acute Ischemic Stroke Drug Manufacturers offering breakthrough solutions
Visualize Transdermal Drug Delivery Systems Market using Verified Market Intelligence -:
Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
About Us
Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance and use industrial techniques to collect and analyze data on more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.
